RenovoRx, Inc. (RNXT) Insider Trading
Over the last 3 months, RNXT insiders made 7 open-market buys and 0 sales, a net purchase of $146K (SEC Form 4). Multiple insiders bought within days of each other (cluster buying). Over the last 6 months, 20 institutions increased and 12 reduced their position (13F).
Insider Activity
Sentiment
100/100
Buys (3m)
7
Sells (3m)
0
Net (3m)
$146.5K
Insiders buyingCluster buying
Insider trades by month Buys Sells
Aug
Nov
Dec
Jan
Mar
May
Context3-month price +6.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 21, 2026 | VOLL MARKofficer: Chief Financial Officer | Buy | 25,000 | $0.79 |
| Apr 7, 2026 | VOLL MARKofficer: Chief Financial Officer | Grant | 80,000 | — |
| Apr 7, 2026 | Agah Ramtindirector, officer: Chief Medical Officer | Grant | 621,727 | $0.98 |
| Apr 7, 2026 | Bagai Shaundirector, officer: Chief Executive Officer | Grant | 946,107 | $0.98 |
| Apr 7, 2026 | Gentry Leesaofficer: Chief Clinical Officer | Grant | 128,550 | $0.98 |
| Mar 27, 2026 | VOLL MARKofficer: Chief Financial Officer | Grant | 12,380 | — |
| Mar 24, 2026 | VOLL MARKofficer: Chief Financial Officer | Buy | 48,600 | $1.93 |
| Mar 24, 2026 | Marton Laurencedirector | Buy | 9,720 | — |
| Mar 24, 2026 | Bagai Shaundirector, officer: Chief Executive Officer | Buy | 12,150 | $1.93 |
| Mar 24, 2026 | Bagai Shaundirector, officer: Chief Executive Officer | Buy | 24,300 | — |
| Mar 24, 2026 | Marton Laurencedirector | Buy | 4,860 | $1.93 |
| Mar 24, 2026 | VOLL MARKofficer: Chief Financial Officer | Buy | 97,200 | — |
| Jan 22, 2026 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 10,000 | $1.00 |
| Jan 5, 2026 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 9,795 | $0.86 |
| Jan 2, 2026 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 205 | $0.83 |
| Dec 22, 2025 | Bagai Shaundirector, officer: Chief Executive Officer | Buy | 5,000 | $0.90 |
| Dec 19, 2025 | Bagai Shaundirector, officer: Chief Executive Officer | Buy | 5,000 | $0.85 |
| Dec 17, 2025 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 12,000 | $0.85 |
| Dec 8, 2025 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 10,000 | $0.96 |
| Nov 24, 2025 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 12,000 | $0.80 |
| Nov 24, 2025 | Agah Ramtindirector, officer: Chief Medical Officer | Buy | 10,000 | $0.80 |
| Oct 3, 2025 | Marton Laurencedirector | Grant | 47,640 | $1.34 |
| Oct 2, 2025 | Macfarlane K. Angeladirector | Grant | 47,640 | $1.34 |
| Oct 2, 2025 | Spiegel Robert J.director | Grant | 47,640 | $1.34 |
| Oct 2, 2025 | RYAN UNA Sdirector | Grant | 47,640 | $1.34 |
| Aug 26, 2025 | Bagai Shaundirector, officer: Chief Executive Officer | Buy | 5,000 | $0.91 |
| Jul 3, 2025 | Bagai Shaundirector, officer: Chief Executive Officer | Grant | 102,498 | $1.27 |
| Jul 3, 2025 | Kocak Ronofficer: VP, Controller and PAO | Grant | 41,600 | $1.27 |
| Jul 3, 2025 | Agah Ramtindirector, officer: Chief Medical Officer | Grant | 63,636 | $1.27 |
| Jul 3, 2025 | Gentry Leesaofficer: Chief Clinical Officer | Grant | 6,619 | $1.27 |
Source: RNXT SEC Form 4 filings, latest May 21, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RNXT positions over the last 6 months (SEC Form 13F).
Increased
20
New positions
12
Reduced
12
Sold out
11
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | Increased | 3.7M | Apr 30, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Increased | 2.8M | Feb 2, 2026 |
| BLEICHROEDER LP | Increased | 1.7M | May 14, 2026 |
| VANGUARD GROUP INC | Unchanged | 1.6M | Jan 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.4M | May 15, 2026 |
| BLEICHROEDER LP | Increased | 600K | Feb 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 382K | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 371K | Feb 9, 2026 |
| WEALTHSPIRE ADVISORS, LLC | Unchanged | 253K | May 1, 2026 |
| WEALTHSPIRE ADVISORS, LLC | New Position | 253K | Feb 13, 2026 |
| CITADEL ADVISORS LLC | Increased | 233K | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 158K | May 8, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 117K | Feb 12, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | Increased | 99K | May 7, 2026 |
| NIXON PEABODY TRUST CO | Unchanged | 97K | Apr 27, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.